Strong Investor Demand Increases Total Investments to $46M In July 2016, Knobbe Martens client Sienna Biopharmaceuticals, Inc. (Sienna), a clinical stage company focused on medical dermatology and aesthetics, announced it…

Partner Jonathan Hyman was quoted in The Washington Post in “Whole Foods just got called out for a pretty big exaggeration.” He discusses the recent rejection of Whole Foods’ trademark…

Applicant’s Claim of Secondary Meaning in MINIMELTS Melts Down Before the Board Mini Melts opposed Reckitt’s intent-to-use applications for “MINI-MELTS” and “MINIMELTS,” alleging a likelihood of confusion with its own…

Obvious Combinations Do Not Need to Be Physically Combinable In Allied Erecting and Dismantling Co., Inc. v. Genesis Attachments, LLC, Appeal No. 2015-1533, the Federal Circuit affirmed the PTAB’s invalidity…

Attorneys Michael Friedland and Samantha Hsu co-authored “The Defend Trade Secrets Act of 2016 – New Federal Protection for Trade Secrets” for the Orange County Business Journal Intellectual Property Law…

Patentees suing alleged infringers have learned from a long history of federal district court and Federal Circuit rulings that (paraphrasing the Miranda warning given to criminal suspects) “anything you say…

In an en banc decision on July 12, 2016 in The Medicines Co. v. Hospira, Inc., the Federal Circuit established the circumstances under which a product manufactured according to product-by-process…

Summary Voters in the U.K. recently passed a referendum paving the way for the U.K. to leave the European Union (EU). In response, British Prime Minister David Cameron resigned on…

The new Post-Prosecution Pilot (“P3”) program provides a pathway for patent applicants to make an in-person presentation to a panel of patent examiners as an alternative to existing options for…

The medical device industry has been struck by a wave of uncertainty in the wake of the United Kingdom’s (UK) historic vote to leave the European Union (EU).  Until the…